Total Payments
$30,357
2024 Payments
$1,822
Companies
48
Transactions
552
Medicare Patients
9,849
Medicare Billing
$892,595
Payment Breakdown by Category
Research$11,531 (38.0%)
Travel$10,367 (34.2%)
Food & Beverage$8,271 (27.2%)
Education$154.63 (0.5%)
Other$33.33 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $11,531 | 3 | 38.0% |
| Travel and Lodging | $10,367 | 8 | 34.2% |
| Food and Beverage | $8,271 | 535 | 27.2% |
| Education | $154.63 | 5 | 0.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $33.33 | 1 | 0.1% |
Payments by Type
General
$18,826
549 transactions
Research
$11,531
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $11,531 | 3 | $0 (2019) |
| Novo Nordisk AS | $10,360 | 8 | $0 (2019) |
| Novo Nordisk Inc | $939.15 | 60 | $0 (2024) |
| Lilly USA, LLC | $804.36 | 61 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $751.62 | 56 | $0 (2024) |
| Janssen Research & Development, LLC | $711.87 | 8 | $0 (2023) |
| PFIZER INC. | $534.82 | 44 | $0 (2024) |
| Amgen Inc. | $505.30 | 40 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $450.12 | 27 | $0 (2024) |
| ABBVIE INC. | $426.81 | 34 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,822 | 111 | Lilly USA, LLC ($252.44) |
| 2023 | $2,052 | 95 | Janssen Research & Development, LLC ($711.87) |
| 2022 | $386.32 | 22 | PFIZER INC. ($66.09) |
| 2020 | $204.07 | 14 | Novartis Pharmaceuticals Corporation ($49.17) |
| 2019 | $11,135 | 88 | Novo Nordisk AS ($9,285) |
| 2018 | $12,105 | 105 | Eli Lilly and Company ($10,808) |
| 2017 | $2,652 | 117 | Novo Nordisk AS ($1,075) |
All Payment Transactions
552 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Diabetes | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/12/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $5.04 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.12 | General |
| Category: Cardiovascular | ||||||
| 11/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: DIABETES | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: RESPIRATORY | ||||||
| 11/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $1.29 | General |
| Category: Diabetes | ||||||
| 11/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $6.44 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: VACCINES | ||||||
| 11/12/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $28.20 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $9.19 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/04/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Oncology | ||||||
| 10/23/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $2.39 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Diabetes | ||||||
| 10/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/18/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: Endocrinology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A STUDY OF LY3209590 IN PARTICIPANTS WITH TYPE 2 DIABETES MELLITUS | Eli Lilly and Company | $11,531 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 2,419 | 3,601 | $540,017 | $239,115 |
| 2022 | 24 | 2,278 | 3,540 | $533,641 | $226,970 |
| 2021 | 25 | 2,504 | 3,883 | $540,309 | $233,605 |
| 2020 | 29 | 2,648 | 3,725 | $476,257 | $192,905 |
Total Patients
9,849
Total Services
14,749
Medicare Billing
$892,595
Procedure Codes
98
All Medicare Procedures & Services
98 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 553 | 1,304 | $285,576 | $107,126 | 37.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 406 | 406 | $90,944 | $50,027 | 55.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 51 | 51 | $17,493 | $14,350 | 82.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 180 | 182 | $14,525 | $13,759 | 94.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 45 | 50 | $23,550 | $10,370 | 44.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 97 | 113 | $17,402 | $7,275 | 41.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 62 | 62 | $17,484 | $6,782 | 38.8% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 160 | 160 | $15,893 | $5,710 | 35.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 182 | 184 | $5,520 | $5,323 | 96.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 352 | 534 | $9,078 | $4,486 | 49.4% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 25 | 26 | $9,074 | $4,022 | 44.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 135 | 342 | $17,100 | $3,256 | 19.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 15 | 15 | $4,275 | $2,384 | 55.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 51 | 51 | $1,530 | $1,475 | 96.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 28 | 33 | $5,041 | $1,119 | 22.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 13 | 13 | $2,457 | $795.86 | 32.4% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 12 | 19 | $1,311 | $563.58 | 43.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 22 | 24 | $528.00 | $151.20 | 28.6% |
| G0403 | Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 2023 | 11 | 11 | $501.16 | $98.64 | 19.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 19 | 21 | $735.00 | $44.00 | 6.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 548 | 1,396 | $305,724 | $111,766 | 36.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 383 | 383 | $85,792 | $47,101 | 54.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 175 | 178 | $13,315 | $12,485 | 93.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 45 | 51 | $24,021 | $10,679 | 44.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 61 | 61 | $17,202 | $6,249 | 36.3% |
About Dr. Carl Sofley, MD
Dr. Carl Sofley, MD is a Internal Medicine healthcare provider based in Anderson, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1316940059.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Carl Sofley, MD has received a total of $30,357 in payments from pharmaceutical and medical device companies, with $1,822 received in 2024. These payments were reported across 552 transactions from 48 companies. The most common payment nature is "" ($11,531).
As a Medicare-enrolled provider, Sofley has provided services to 9,849 Medicare beneficiaries, totaling 14,749 services with total Medicare billing of $892,595. Data is available for 4 years (2020–2023), covering 98 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Anderson, SC
- Active Since 05/26/2005
- Last Updated 05/25/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1316940059
Products in Payments
- Ozempic (Drug) $9,562
- ENTRESTO (Drug) $570.36
- JARDIANCE (Drug) $439.12
- MOUNJARO (Drug) $295.31
- TOUJEO (Drug) $231.75
- UBRELVY (Drug) $207.49
- Vascepa (Drug) $201.97
- ELIQUIS (Drug) $188.08
- LEQVIO (Drug) $181.26
- FARXIGA (Drug) $175.49
- REXULTI (Drug) $174.09
- Victoza (Drug) $165.21
- TRELEGY ELLIPTA (Drug) $160.56
- GVOKE HYPOPEN (Drug) $158.76
- BREZTRI (Drug) $158.36
- TRULICITY (Drug) $156.53
- CHANTIX (Drug) $153.83
- Aimovig (Biological) $152.82
- TRADJENTA (Drug) $146.14
- Prolia (Biological) $129.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Anderson
Abhijit Raval, Md, MD
Internal Medicine — Payments: $1.9M
Internal Medicine $1.9M
Christopher Jennings, Md, MD
Internal Medicine — Payments: $1.4M
Internal Medicine $1.4M
Dr. Anita Vagnoni, Md, MD
Internal Medicine — Payments: $55,715
Internal Medicine $55,715
James Mcclain, M.d, M.D
Internal Medicine — Payments: $23,421
Internal Medicine $23,421
Robert Anderson, Md, MD
Internal Medicine — Payments: $13,599
Internal Medicine $13,599
Wael Bakdash, M.d, M.D
Internal Medicine — Payments: $12,031
Internal Medicine $12,031